21.75MMarket Cap-641P/E (TTM)
2.680High2.600Low4.65KVolume2.670Open2.590Pre Close12.32KTurnover0.09%Turnover RatioLossP/E (Static)8.12MShares4.55052wk High0.80P/B14.24MFloat Cap2.41052wk Low--Dividend TTM5.31MShs Float36.720Historical High--Div YieldTTM3.09%Amplitude2.410Historical Low2.649Avg Price1Lot Size
Lumos Pharma Stock Forum
Let’s see what good stuff comes from these?
AUSTIN, TX, April 18, 2024 (GLOBE NEWSWIRE) – Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) through Phase 2 clinical trials, announced today that abstracts reviewing data from its Phase 2 OraGrowtH210 and OraGrowtH212 Trials will be presented...
News
Update
Seminar Started
Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
Today's trading is a short-seller's fiesta, but long players aren't left in the dust either!
✅ CDIO bucked the trend with a strategic 13.04% LONG MOVE and nimbly dipped 13.99% on the short side!
💥 HSCS is the short sensation, dropping a massive 57.85%!
💣 BIOL, LUMO, and BYU are making waves with short moves of 18.99%, 18.66%, and a whopping 27.34%, respectively!
See you all tomorrow AM for another rou...
bullish
🔔 🔍 Lens Focused, Market Observers! New Day on the Horizon! 🔔
Still energized from YESTERDAY'S 48% LONG MOVE? Let's channel that momentum into today’s action:
✅1️⃣ HSCS Long > 0.5135 Short < 0.4745
✅2️⃣ BIOL Long > 2.01 Short < 1.79
✅3️⃣ LUMO Long > 4.84 Short < 4.61
✅4️⃣ CDIO Long > 1.61 Short < 1.43
✅5️⃣ BYU Long > 3.11 Short < 2.89
Armed with insight, let’s dominate today’s session. Watch this space for our strategic plays! 📈💥
Hehehe
No comment yet